Oncology
5,302 studies557 in 7 days2,546 in 30 days
Filters
Latest
5,302 studies
- Smoking status and survival by cancer type and treatment intent in a population-based cohort with adjustment for major prognostic factors.
- Neoadjuvant versus adjuvant chemotherapy in luminal B-like breast cancer: a subset analysis of the CANTO study.
- Anterior mediastinal epithelioid hemangioendothelioma associated with myelolipoma and extramedullary hematopoiesis mimicking a mature teratoma: A radiologic-pathologic correlation.
- Older adults’ experiences of adapting to changes after colorectal cancer surgery in Sweden: a qualitative study
- CAR-T-cell therapy for autoimmune neurologic diseases
- Chimeric antigen receptor-engineered cell therapy for asthma: advances in targeting type 2 inflammation and translational challenges
- Circulating Immune-Related Biomarkers in Egyptian Women with Early Breast Cancer: An Exploratory Case–Control Study Across IHC-Defined Clinicopathological Subgroups
- Integrative multi-omics analysis identifies CCDC69 as a marker associated with germinal center B-cell infiltration in TNBC: development and validation.
- Decoding chromatin-associated RNA (caRNA) interaction networks: from genome-wide dynamic capture to epigenetic mechanisms in plants and animals.
- Cell-resolved spatial mapping of antibody-drug conjugate targets in breast cancer.
- De-escalation of axillary surgery in clinically node-negative (cN0) breast cancer: current evidence, advances, and controversies
- NHC-Au-Xanthate Complexes: Selective Cytotoxic Activity and Mechanistic Insights
- Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy
- Hypoxia-inducible factor-1α–mediated metabolic reprogramming in sepsis-associated organ dysfunction: organ-specific metabolic mismatch and therapeutic perspectives
- Nutritional regulation of the tumor immune microenvironment: metabolic mechanisms, immunotherapy response, and nursing implications
- Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation
- Spatial architecture shapes programmed cell death-associated immune niches and therapeutic resistance in clear cell renal cell carcinoma
- Osteoclast-like giant cell variant of bladder urothelial carcinoma with poor response to neoadjuvant chemotherapy managed by robot-assisted radical cystoprostatectomy: A case report
- Epigenetic rewiring of immunological memory in cancer: heterogeneity, mechanisms, and therapeutic vulnerabilities
- Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integration
- Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidence
- Metabolic sensing in 3D models of pancreatic ductal adenocarcinoma: probing pH, oxygen, and lactate dynamics to decode chemoresistance
- Low-affinity anti-HER2-CAR T cells efficiently eradicate HER2+ and HER2low cancer cells with reduced toxicity on healthy tissue
- Regulation of the Human Cyclin-dependent Kinase Inhibitor p18 by the Transcription Factors E2F1 and Sp1
- A Common Set of Gene Regulatory Networks Links Metabolism and Growth Inhibition